Protein O-fucosyltransferase 1 (Pofut1) regulates lymphoid and myeloid homeostasis through modulation of Notch receptor ligand interactions

Blood

Volumn 117, Issue 21, 2011, Pages 5652-5662

  Yao, David ^a   Huang, Yuanshuai ^b   Huang, Xiaoran ^a   Wang, Weihuan ^a   Yan, Quanjian ^a   Wei, Lebing ^a   Xin, Wei ^a   Gerson, Stanton ^c   Stanley, Pamela ^d   Lowe, John B ^e   Zhou, Lan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSYLTRANSFERASE; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PROTEIN O FUCOSYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME INACTIVATION; HETEROZYGOSITY; HOMEOSTASIS; LIGAND BINDING; LYMPHATIC SYSTEM DISEASE; LYMPHOID CELL; LYMPHOID HYPERPLASIA; LYMPHOPOIESIS; MOLECULAR INTERACTION; MOUSE; MYELOID HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 79957607092     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-12-326074     Document Type: Article

References (50)

1. Artavanis-Tsakonas S, Muskavitch MA. Notch: the past, the present, and the future. Curr Top Dev Biol. 2010;92:1-29.
2. Moloney DJ, Panin VM, Johnston SH, et al. Fringe is a glycosyltransferase that modifies Notch. Nature. 2000;406(6794):369-375. (Pubitemid 30625549)
3. Wang Y, Shao L, Shi S, et al. Modification of epidermal growth factor-like repeats with O-fucose: molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase. J Biol Chem. 2001;276(43):40338-40345.
4. Luo Y, Haltiwanger RS. O-fucosylation of notch occurs in the endoplasmic reticulum. J Biol Chem. 2005;280(12):11289-11294. (Pubitemid 40418435)
5. Okajima T, Xu A, Lei L, Irvine KD. Chaperone activity of protein O-fucosyltransferase 1 promotes notch receptor folding. Science. 2005;307(5715):1599-1603. (Pubitemid 40354738)
6. Bruckner K, Perez L, Clausen H, Cohen S. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature. 2000;406(6794):411-415. (Pubitemid 30625560)
7. Moloney DJ, Shair LH, Lu FM, et al. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J Biol Chem. 2000;275(13):9604-9611. (Pubitemid 30185192)
8. Haines N, Irvine KD. Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol. 2003;4(10):786-797. (Pubitemid 37229375)
9. Haltiwanger RS, Lowe JB. Role of glycosylation in development. Annu Rev Biochem. 2004;73:491-537. (Pubitemid 39050378)
10. Stanley P, Okajima T. Roles of glycosylation in Notch signaling. Curr Top Dev Biol. 2010;92:131-164.
11. Koch U, Lacombe TA, Holland D, et al. Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity. 2001;15(2):225-236. (Pubitemid 32816872)
12. Visan I, Tan JB, Yuan JS, Harper JA, Koch U, Guidos CJ. Regulation of T lymphopoiesis by Notch1 and Lunatic fringe-mediated competition for intrathymic niches. Nat Immunol. 2006;7(6):634-643. (Pubitemid 43797345)
13. Lu L, Stanley P. Roles of O-fucose glycans in notch signaling revealed by mutant mice. Methods Enzymol. 2006;417:127-136. (Pubitemid 44792706)
14. Tan JB, Xu K, Cretegny K, et al. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. Immunity. 2009;30(2):254-263.
15. Visan I, Yuan JS, Liu Y, Stanley P, Guidos CJ. Lunatic fringe enhances competition for delta-like Notch ligands but does not overcome defective pre-TCR signaling during thymocyte beta-selection in vivo. J Immunol. 2010;185(8):4609-4617.
16. Okajima T, Irvine KD. Regulation of notch signaling by o-linked fucose. Cell. 2002;111(6):893-904. (Pubitemid 36109160)
17. Okajima T, Xu A, Irvine KD. Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe. J Biol Chem. 2003;278(43):42340-42345. (Pubitemid 37310503)
18. Shi S, Stanley P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc Natl Acad Sci U S A. 2003;100(9):5234-5239. (Pubitemid 36542688)
19. Okamura Y, Saga Y. Pofut1 is required for the proper localization of the Notch receptor during mouse development. Mech Dev. 2008;125(8):663-673.
20. Smith PL, Myers JT, Rogers CE, et al. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol. 2002;158(4):801-815. (Pubitemid 34920117)
21. Zhou L, Li LW, Yan Q, et al. Notch-dependent control of myelopoiesis is regulated by fucosylation. Blood. 2008;112(2):308-319.
22. Yan Q, Yao D, Wei LL, et al. O-fucose modulates notch-controlled blood lineage commitment. Am J Pathol. 2010;176(6):2921-2934.
23. Myers J, Huang Y, Wei L, Yan Q, Huang A, Zhou L. Fucose-deficient hematopoietic stem cells have decreased self-renewal and aberrant marrow niche occupancy. Transfusion. 2010;50(12):2660-2669.
24. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell. 1996;84(4):563-574. (Pubitemid 26071737)
25. Ge C, Stanley P. The O-fucose glycan in the ligand-binding domain of Notch1 regulates embryogenesis and T-cell development. Proc Natl Acad Sci U S A. 2008;105(5):1539-1544. (Pubitemid 351346550)
26. Ge C, Liu T, Hou X, Stanley P. In vivo consequences of deleting EGF repeats 8-12 including the ligand binding domain of mouse Notch1. BMC Dev Biol. 2008;8:48.
27. Ge C, Stanley P. Effects of varying Notch1 signal strength on embryogenesis and vasculogenesis in compound mutant heterozygotes. BMC Dev Biol. 2010;10:36.
28. Rampal R, Luther KB, Haltiwanger RS. Notch signaling in normal and disease states: possible therapies related to glycosylation. Curr Mol Med. 2007;7(4):427-445. (Pubitemid 46979706)
29. Luo Y, Koles K, Vorndam W, Haltiwanger RS, Panin VM. Protein O-fucosyltransferase 2 adds O-fucose to thrombospondin type 1 repeats. J Biol Chem. 2006;281(14):9393-9399. (Pubitemid 43864655)
30. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269(5229):1427-1429.
31. Saito T, Chiba S, Ichikawa M, et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 2003;18(5):675-685. (Pubitemid 36588584)
32. Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10(5):547-558. (Pubitemid 29262657)
33. Harris RJ, Spellman MW. O-linked fucose and other post-translational modifications unique to EGF modules. Glycobiology. 1993;3(3):219-224. (Pubitemid 23232156)
34. Schiffer SG, Foley S, Kaffashan A, et al. Fucosylation of Cripto is required for its ability to facilitate nodal signaling. J Biol Chem. 2001;276(41):37769-37778.
35. Kim ML, Chandrasekharan K, Glass M, et al. O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptors. Mol Cell Neurosci. 2008;39(3):452-464.
36. Georgiades P, Ogilvy S, Duval H, et al. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis. 2002;34(4):251-256. (Pubitemid 35470699)
37. Okajima T, Reddy B, Matsuda T, Irvine KD. Contributions of chaperone and glycosyltransferase activities of O-fucosyltransferase 1 to Notch signaling. BMC Biol. 2008;6:1.
38. Stahl M, Uemura K, Ge C, Shi S, Tashima Y, Stanley P. Roles of Pofut1 and O-fucose in mammalian Notch signaling. J Biol Chem. 2008;283(20):13638-13651.
39. Ryan MJ, Bales C, Nelson A, et al. Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype. Hepatology. 2008;48(6):1989-1997.
40. Beck DJ. Genetic and biochemical determinants of fucosylated glycan expression. PhD thesis. Ann Arbor, MI: University of Michigan; 2002.
41. Han H, Tanigaki K, Yamamoto N, et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol. 2002;14(6):637-645. (Pubitemid 34649719)
42. Rampal R, Arboleda-Velasquez JF, Nita-Lazar A, Kosik KS, Haltiwanger RS. Highly conserved O-fucose sites have distinct effects on Notch1 function. J Biol Chem. 2005;280(37):32133-32140. (Pubitemid 41361819)
43. Visan I, Yuan JS, Tan JB, Cretegny K, Guidos CJ. Regulation of intrathymic T-cell development by Lunatic Fringe-Notch1 interactions. Immunol Rev. 2006;209:76-94.
44. Moran JL, Shifley ET, Levorse JM, et al. Manic fringe is not required for embryonic development, and fringe family members do not exhibit redundant functions in the axial skeleton, limb, or hindbrain. Dev Dyn. 2009;238(7):1803-1812.
45. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216-233.
46. Panin VM, Shao L, Lei L, Moloney DJ, Irvine KD, Haltiwanger RS. Notch ligands are substrates for protein O-fucosyltransferase-1 and Fringe. J Biol Chem. 2002;277(33):29945-29952.
47. Shimizu K, Chiba S, Kumano K, et al. Mouse jagged1 physically interacts with notch2 and other notch receptors: assessment by quantitative methods. J Biol Chem. 1999;274(46):32961-32969. (Pubitemid 129535335)
48. Kim YW, Koo BK, Jeong HW, et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood. 2008;112(12):4628-4638.
49. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425(6960):841-846. (Pubitemid 37351468)
50. Butler JM, Nolan DJ, Vertes EL, et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell. 2010;6(3):251-264.